Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides FY13 EPS Below Views
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.19, $0.02 better than the analyst estimate of $1.17. Revenue for the quarter came in at $17.6 billion versus the consensus estimate of $17.67 billion.
Johnson & Johnson sees FY2013 EPS of $5.35-.5.45, versus the consensus of $5.49.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Johnson & Johnson sees FY2013 EPS of $5.35-.5.45, versus the consensus of $5.49.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.